| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |